| Authors: |
Maura F; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. mauraf@mskcc.org.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. mauraf@mskcc.org., Kaddoura M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Poos AM; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany., Baughn LB; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Ziccheddu B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Bärtsch MA; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany., Cirrincione A; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Chojnacka M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Diamond B; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York City, NY, USA., John L; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany., Reichert P; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany., Huhn S; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany., Gagler D; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York City, NY, USA., Zhang Y; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Dogan A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Lesokhin AM; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Davies F; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York City, NY, USA., Goldschmidt H; Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Study Group, Heidelberg University Hospital and the National Center for Tumor Diseases (NCT), Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany., Weisel KC; Department of Oncology, Hematology, and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mai EK; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany., Korde N; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York City, NY, USA., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Usmani S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Raab MS; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de. |
